Phase 3 EMBARK: Enzalutamide + Leuprolide Prostate Cancer ESMO 2023 Prostate 2 Mins Read1 By: Neal Shore, MD Date: October 25, 2023 In the abstract describing the EMBARK Phase 3 trial, Dr. Neal Shore…
Module #1: Maximizing Current Therapies and Exploring Future Directions as PARP Inhibitors Take the Stage in Prostate Cancer Prostate 1 Min Read1 This curriculum features expert commentaries and case discussions that synthesize data around PARP inhibition and its evolving place in the…
